Share-based Payment Arrangements | (3) Share-based Payment Arrangements As of September 29, 2018, the Company had two employee equity incentive plans, the 2002 employee stock option and stock incentive plan (the “ESOSIP”) and the 2011 equity incentive plan (the “2011 EIP”). No further grants can be made under the ESOSIP. The Company also has a stock compensation plan for members of its Board of Directors, the Amended and Restated 2013 Directors Stock Compensation Plan (as amended and restated as of May 17, 2016, the “2013 DSCP”). 6,000,000 shares of the Company’s common stock were authorized for issuance under the 2011 EIP and 115,000 shares of the Company’s common stock were authorized for issuance under the 2013 DSCP. The ESOSIP, 2011 EIP and 2013 DSCP are each referred to herein as a “Plan,” and, collectively, as the “Plans.” Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands): Thirty Nine Weeks Ended Thirteen Weeks Ended September 29, 2018 September 30, 2017 September 29, 2018 September 30, 2017 Total cost of the Plans during the period $ 13,003 $ 3,660 $ 4,901 $ 1,423 Amount of related income tax benefit recognized during the period (5,305 ) (2,492 ) (1,837 ) (678 ) Net cost of the Plans during the period $ 7,698 $ 1,168 $ 3,064 $ 745 Included in income tax benefits recognized in the thirty-nine-week periods ended September 29, 2018 and September 30, 2017 were income tax benefits of $80,000 and $310,000, respectively, recognized on disqualifying dispositions of the Company’s common stock by employees who obtained shares of common stock through exercises of incentive stock options. Also included in income tax benefits recognized in the thirty-nine-week periods ended September 29, 2018 and September 30, 2017 were excess tax benefits from stock-based awards of $2,046,000 and $868,000, respectively. As of September 29, 2018, there were 72,742 shares of the Company’s common stock reserved for issuance under the 2013 DSCP and 4,439,761 shares of the Company’s common stock reserved for issuance in the aggregate under the ESOSIP and 2011 EIP. Restricted Stock Units The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans: Number Weighted Average Grant Date Fair Value Outstanding at December 30, 2017 387,372 $ 55.75 Granted 65,494 $ 96.08 Vested (67,971 ) $ 53.92 Forfeited (92,880 ) $ 52.36 Outstanding at September 29, 2018 292,015 $ 66.30 During the thirty-nine-week period ended September 29, 2018, the Company granted RSUs with a performance condition and RSUs with a market condition, as further described below. Outstanding RSUs at both December 30, 2017 and September 29, 2018 include RSUs with a performance condition and RSUs with a market condition, as further described in the Company’s 2017 Annual Report on Form 10-K. RSUs with a performance condition granted on February 2, 2018 may vest on January 31 of 2021, 2022 and 2023 based on growth in operating income and pre-tax On April 24, 2018, the Company granted 9,324 RSUs that vest based on a market condition. These RSUs may vest on June 30 of 2022, 2023 and 2024 based on the Company’s total shareholder return (“TSR”) compound annual growth rate over the vesting periods, adjusted to reflect dividends (if any) paid during such periods and capital adjustments as may be necessary. The maximum number of common shares available for issuance under the April 24, 2018 grant equals 150% of the number of RSUs granted. The fair value of this RSU award was determined at the time of grant based on the expected achievement of the market condition at the end of each vesting period. With respect to these RSU awards, the Company reports compensation expense ratably over the life of the award based on an estimated number of units that will vest over the life of the award, multiplied by the fair value of the RSU. Previously recognized compensation cost would be reversed only if the employee terminated employment prior to completing the requisite service period. The Company recognized approximately $11,303,000 and $2,254,000 of share-based compensation expense related to RSU awards in the thirty-nine-week periods ended September 29, 2018 and September 30, 2017, respectively. As of September 29, 2018, there was a maximum of $23.1 million of total unrecognized compensation cost related to RSU awards granted under the Plans with an expected average remaining life of approximately 3.3 years. With respect to RSU awards with a performance condition, the amount of future compensation expense to be recognized will be determined based on future operating results. Stock Options The following table summarizes information regarding the Company’s outstanding stock options under the Plans: Number of Weighted Average per Share Weighted Average Term (years) Aggregate Intrinsic Options outstanding at December 30, 2017 189,040 $ 49.34 Exercised (97,676 ) $ 48.38 Options outstanding at September 29, 2018 91,364 $ 50.36 3.3 $ 6,546 Options exercisable at September 29, 2018 90,364 $ 50.27 3.3 $ 6,482 The total intrinsic value of stock options exercised during the thirty-nine-week periods ended September 29, 2018 and September 30, 2017 was $6,584,000 and $5,303,000, respectively. As of September 29, 2018, there was no unrecognized compensation cost related to non-vested Non-vested The following table summarizes information regarding the Company’s outstanding shares of non-vested Number of Shares and Deferred Stock Weighted Average Grant Date Fair Value Non-vested 54,755 $ 78.02 Granted 22,803 $ 113.35 Vested (19,814 ) $ 75.11 Forfeited (1,757 ) $ 71.12 Non-vested 55,987 $ 93.66 The fair value of each share of non-vested non-vested As of September 29, 2018, there was $3,756,000 of total unrecognized compensation cost related to non-vested non-vested |